Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry-Reference-Cited by-同舟云学术

Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry

Published:2024-04 Issue:4 Volume:50 Page:108245
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Loveland-Jones Catherine,Gaughan John,Caudle Abigail,Murphy Brittany^ORCID,Samiian Laila,Byrum Stephanie,Brill Kristen,Germaine Pauline^ORCID,Zhang Xinmin,Yoon-Flannery Kay,Carter Teralyn,Lopez Adrian^ORCID,Gruner Ryan,Fantazzio Michele,Kuerer Henry

Publisher

Elsevier BV

Reference14 articles.

1. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection;Caudle;J Clin Oncol,2016

2. Management of the axilla in early-stage breast cancer: ontario Health (cancer care ontario) and ASCO guideline;Brackstone;J Clin Oncol,2021

3. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study;Boileau;J Clin Oncol,2015

4. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial;Boughey;JAMA,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy;American Society of Clinical Oncology Educational Book;2024-06